Log In
Print this Print this

metronidazole (FP110)

  Manage Alerts
Collapse Summary General Information
Company Formac Pharmaceuticals N.V.
DescriptionModified-release formulation of metronidazole
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationInflammatory bowel disease (IBD)
Indication DetailsTreat pouchitis
Regulatory Designation U.S. - Orphan Drug (Treat pouchitis);
EU - Orphan Drug (Treat pouchitis)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today